responding to 3 separate queries re: NRs' *set up* my

New Post Public Reply Private Reply Replies (0) Message Board
4kids 4kids #60162
506
responding to 3 separate queries re: NRs' *set up*

my PM to one IPI investor just now as to (take up/take down)

=================================

i think it is a 50/50 toss right now

2 weeks ago yesterday .. 100k went off in the last 10 minutes of the trading day
(IPIX closed up)

due to that *effort* .. I expected to see an 8K filed the following Monday AM
instead what came was a PR out of IPI

September 16, 2019
INNOVATION PHARMACEUTICALS ANNOUNCES SUCCESSFUL FORMULATION OF ORAL BRILACIDIN TABLETS; UPCOMING CLINICAL TRIAL TO TARGET DELIVERY TO THE COLON

http://www.ipharminc.com/press-release

but what was interesting to me that week .. was what I was seeing on the *ask*
side for several days .. a *thinned* out ask side .. we also saw IPIX taken up to
18c (meaning NR wasn't *blocking* on the ask as has been the norm for most of 2019)

 09/19/2019	0.125	0.18	0.125	0.1389	410,404 


So that makes me suspect that NR does *anticipate* news of a material event
and I am not referring to the 10K

As I've noted to others (who've asked) .. I'm watching to see when the 10K is filed

It may (most likely) be filed Monday ( edited in ) (AH/s presumably) .. and then I'd be watching to see when (could be 10.1.19 or not) IPI files their next PR or files an 8K

But thinking outside of the box here .. It also won't surprise me if IPI files an NT
(delay on the 10K being filed) .. if mgmt needs additional time to finalize what I
believe pertains to this:

Quote:
“Leo said that he will provide more clarity in the coming weeks. “A new direction, a new understanding of what’s going on, actually growing the company, not shrinking it.”


Read More: https://investorshangout.com/post/view?id=554...z60qArU2EY

So to answer your query .. I can see NR trying to do another *CONtrolled* take up on IPIX to negate impact of what *imo* NR expects .. as NR so aptly and ably did in early May 2019 to negate this:

May 16, 2019
INNOVATION PHARMACEUTICALS ANNOUNCES NON-BINDING TERM SHEET SIGNED WITH GLOBAL PHARMACEUTICAL COMPANY TO DEVELOP AND COMMERCIALIZE BRILACIDIN FOR ULCERATIVE PROCTITIS/PROCTOSIGMOIDITIS

http://www.ipharminc.com/press-release

Or .. NR will do the opposite to reset the 7c 52 week low on IPIX ( 12.31.18 ) that was done on mostly bogus *volume* injected by NR via one hell of a gamble beginning last September 12th (2018) .

If NR does a *CONtrolled* take up on IPIX .. imo worth noting *ask* side from
early May and week of *vote tally* (a 90% dagger to NRs' heart *imo*)

IPIX *ask* @ EOD on 5.1.19 (NRs' test *imo* done .. and over with by 11:04 on 5.3.19 )
 
CDEL 0.1595 6,000 15:48
ETRF 0.1598 8,000 15:51
PAUL 0.164 5,000 14:57
CSTI 0.165 5,000 13:49
NITE 0.17 10,000 15:23
CFGN 0.19 5,000 11:45
VERT 0.20 2,500 02/05
VNDM 0.20 2,500 04/30
CANT 0.20 2,500 08:30
LAFC 0.27 2,500 04/10
PUMA 0.35 2,500 08:10
STXG 2.00 100 02/19
MAXM 8.00 100 07:35
INTL U 0 10/24
DBOX U 0 01/22


IPIX *ask* @ EOD on 9.16.19
 
CDEL 0.14 10,000 13:14
NITE 0.1445 5,000 09:56
ETRF 0.1595 25,000 11:57
GTSM 0.1819 5,000 09/13
CFGN 0.199 5,000 07/29
CSTI 0.25 2,500 08:30
PUMA 0.40 2,500 08:10
VERT 0.45 2,500 05/17
VNDM 0.45 2,500 09/13
OTCX 1.00 100 09:30
STXG 2.00 100 02/19
MAXM 8.00 100 07:35


So my best guess is *if* NR does another CONtrolled take up to reset on IPIX
NR will do their utmost to keep within range of last round (possibly higher).
Again I can only note where *imo* NR first started their cycles of money on CTIX
(IPIX) in September 2012 .. 70c (significant price point by NR when *stall* was in play too).

May 2019 's *effort* took a month to *do* and encompassed another
record setting *volume* day on IPIX .. PPS high and low noted below:
 
05/01/2019 0.142 0.17 0.142 0.1595 396,482
05/08/2019 0.435 0.4351 0.3103 0.345 2,366,980


and *imo* since I'm not a fan of coincidences .. the record setting *volume* day
had two other dates where IPIX/CTIX saw 4M~ in *volume*

I suspect it will come as no surprise to anyone following NRs' bouncing *efforts*
to see December 2014 .. August 2015 & May 2019's *volume* .. align .
 
12/08/2014 3.41 4.64 3.4 4.49 4,265,945
08/06/2015 2.47 2.57 1.52 1.71 4,181,492
05/16/2019 0.213 0.33 0.21 0.32 4,413,783


Sorry for lengthy response .. but NRs' *efforts* have been interwoven since NR
first created cycles of money on CTIX back in September 2012 .. and when
a *target* doesn't die due to NRs' *handoff* (EO 2014 into 2015 for IPIX/CTIX) ..

NR has 3 options ..

Flood SMBs .. with 99% negative posts .. to *stall to outlast retail investors and mgmt*

the vote tally courtesy of IPI's SM on 9.16.19 .. puts paid to that effort *imo*
no one with interest can ignore investor response of 90%
but I will reiterate .. for most of 2019 .. NR has held IPIX in a very tight PPS *range*

Aggressively and relentlessly brutalize target's PPS and do so with *volume*
that allows *embeds* to create FUD as to *volume's* origination


that was undertaken on 9.12.18 .. with *effort* resulting in a 7c 52 week low on 12.31.18 .. it is SOP on the OTC and not remotely unique to IPI/IPIX

Lastly .. NR when caught in a trap of their own creation will illegally manipulate an
orchestrated PPS *take up* .. ( May 2019 )


see above for NRs' efforts (PPS & Volume) for that effort earlier this year ..

as always .. best to all actual Innovation Pharma investors ..

4kids


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 21

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 16

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 7

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 17

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 23

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 20

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 13

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 14

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 20

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading

Top 5 Most Recently Viewed Articles

Oscar Health Expands Services to Families in North Carolina Areas

Updated Category News Views 51

Oscar Health Enters North Carolina Markets Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a prominent player in healthcare technology, is set to unveil its innovative services in the Charlotte and Winston-Salem regions. With a focus on providing exceptional healthcare experiences, Oscar aims to enhance the lives of individuals and families through the ACA marketplace,...

Continue Reading
Helius Medical Technologies to Showcase Innovations at Key Conference

Updated Category News Views 35

Introduction to Helius Medical Technologies Helius Medical Technologies, Inc. is a pioneering neurotechnology company focused on developing innovative therapeutic solutions aimed at addressing neurogenic balance and gait disorders. Known for its commitment to enhancing patient outcomes, Helius has made significant strides in the medical device sector by offering...

Continue Reading
AM Best Assigns Credit Rating to CSAA Insurance Exchange's Notes

Updated Category News Views 444

AM Best Grants Elevated Credit Rating to CSAA Insurance Exchange In a notable development within the finance sector, AM Best has recently assigned a Long-Term Issue Credit Rating of "a-" (Excellent) to the surplus notes issued by CSAA Insurance Exchange. This issuance amounts to an impressive $500 million, with an 8.125% interest rate due in February 2045. It’s...

Continue Reading
Quoin Pharmaceuticals Set to Reveal Financial Performance Soon

Updated Category News Views 81

Quoin Pharmaceuticals to Unveil Financial Highlights Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a pioneering company in the specialty pharmaceutical sector, is gearing up to announce its financial results for the second quarter. This significant update is expected to occur before the markets open in the near future, reflecting the company’s ongoing commitment to the...

Continue Reading
Bitcoin Frontier Fund Expands Leadership with Dr. Chiente Hsu

Updated Category News Views 200

Bitcoin Frontier Fund Announces Dr. Chiente Hsu as General Partner Bitcoin Frontier Fund (BFF), a prominent venture capital firm dedicated to promoting early-stage Bitcoin startups, is thrilled to share the exciting news of Dr. Chiente Hsu joining the team as General Partner. Dr. Hsu brings with her a wealth of experience accumulated over decades in traditional finance,...

Continue Reading